Skip navigation

Treatment of neurodegenerative conditions

Treatment of neurodegenerative conditions

BTG International Ltd (2010) Treatment of neurodegenerative conditions. US2010/0113810 A1.

Full text not available from this repository.


A method is provided for treating a patient in need of therapy for a neurodegenerative disease comprising administering to that patient a therapeutically effective dose of a lipid glyceride comprising a glycerol moiety and a fatty acid moiety, the fatty acid moiety being selected from the group consisting of γ-linolenic acid, dihomo-γ-linolenic acid and arachidonic acid characterised in that the selected fatty acid moiety is attached to the glycerol moiety at its sn-2 position. Preferably the method is that wherein the lipid is administered for a duration and at a dose sufficient to maintain or elevate TGF-β1 levels in the patient to therapeutic levels.

Item Type: Patent
Uncontrolled Keywords: polyunsaturated fatty acids, treatment of multiple sclerosis
Subjects: R Medicine > R Medicine (General)
Faculty / School / Research Centre / Research Group: Faculty of Education, Health & Human Sciences > School of Human Sciences (HUM)
Last Modified: 09 Oct 2021 04:46

Actions (login required)

View Item View Item